263 related articles for article (PubMed ID: 8798456)
1. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin.
Mimnaugh EG; Chavany C; Neckers L
J Biol Chem; 1996 Sep; 271(37):22796-801. PubMed ID: 8798456
[TBL] [Abstract][Full Text] [Related]
2. Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.
Magnifico A; Tagliabue E; Ardini E; Casalini P; Colnaghi MI; Ménard S
FEBS Lett; 1998 Jan; 422(2):129-31. PubMed ID: 9489990
[TBL] [Abstract][Full Text] [Related]
3. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
Whitesell L; Sutphin P; An WG; Schulte T; Blagosklonny MV; Neckers L
Oncogene; 1997 Jun; 14(23):2809-16. PubMed ID: 9190897
[TBL] [Abstract][Full Text] [Related]
4. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
Zhou M; Fisher EA; Ginsberg HN
J Biol Chem; 1998 Sep; 273(38):24649-53. PubMed ID: 9733761
[TBL] [Abstract][Full Text] [Related]
5. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.
Mimnaugh EG; Xu W; Vos M; Yuan X; Isaacs JS; Bisht KS; Gius D; Neckers L
Mol Cancer Ther; 2004 May; 3(5):551-66. PubMed ID: 15141013
[TBL] [Abstract][Full Text] [Related]
7. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.
Loo MA; Jensen TJ; Cui L; Hou Y; Chang XB; Riordan JR
EMBO J; 1998 Dec; 17(23):6879-87. PubMed ID: 9843494
[TBL] [Abstract][Full Text] [Related]
9. Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat.
Piechocki MP; Pilon SA; Kelly C; Wei WZ
Cell Immunol; 2001 Sep; 212(2):138-49. PubMed ID: 11748930
[TBL] [Abstract][Full Text] [Related]
10. The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase.
Ochel HJ; Schulte TW; Nguyen P; Trepel J; Neckers L
Mol Genet Metab; 1999 Jan; 66(1):24-30. PubMed ID: 9973544
[TBL] [Abstract][Full Text] [Related]
11. Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation.
Tikhomirov O; Carpenter G
J Biol Chem; 2000 Aug; 275(34):26625-31. PubMed ID: 10862618
[TBL] [Abstract][Full Text] [Related]
12. CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins.
Doong H; Rizzo K; Fang S; Kulpa V; Weissman AM; Kohn EC
J Biol Chem; 2003 Aug; 278(31):28490-500. PubMed ID: 12750378
[TBL] [Abstract][Full Text] [Related]
13. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.
Jeffers M; Taylor GA; Weidner KM; Omura S; Vande Woude GF
Mol Cell Biol; 1997 Feb; 17(2):799-808. PubMed ID: 9001234
[TBL] [Abstract][Full Text] [Related]
14. Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.
Castilleja A; Ward NE; O'Brian CA; Swearingen B; Swan E; Gillogly MA; Murray JL; Kudelka AP; Gershenson DM; Ioannides CG
Mol Cell Biochem; 2001 Jan; 217(1-2):21-33. PubMed ID: 11269662
[TBL] [Abstract][Full Text] [Related]
15. Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell lines.
Hartmann F; Horak EM; Cho C; Lupu R; Bolen JB; Stetler-Stevenson MA; Pfreundschuh M; Waldmann TA; Horak ID
Int J Cancer; 1997 Jan; 70(2):221-9. PubMed ID: 9009164
[TBL] [Abstract][Full Text] [Related]
16. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
Schulte TW; An WG; Neckers LM
Biochem Biophys Res Commun; 1997 Oct; 239(3):655-9. PubMed ID: 9367823
[TBL] [Abstract][Full Text] [Related]
17. [Ligand-induced polyubiquitination of receptor tyrosine kinases].
Mori S
Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2284-90. PubMed ID: 9366209
[No Abstract] [Full Text] [Related]
18. Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein.
Bonvini P; Dalla Rosa H; Vignes N; Rosolen A
Cancer Res; 2004 May; 64(9):3256-64. PubMed ID: 15126367
[TBL] [Abstract][Full Text] [Related]
19. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
20. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.
An WG; Schulte TW; Neckers LM
Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]